Boards
Bundled experience and expertise strengthen our company’s development.
Christian M. Pangratz
Seed Investor / Founding ShareholderBusiness administration, management and start-up expert
More than 25 years of international marketing & sales, business development and corporate development experience in Europe, USA and Asia
Industry expertise in biotechnology, pharmaceuticals and medical devices
Comprehensive track record consisting of fundraising for equity financings of over 32 million Euros and license agreements, product and company sales with cumulative transaction value of over US$ 4.5 billion
Angel Investor, Non-Executive Board Member and Investor Advisor
Dr. Georg Matheis
InvestorSuccessful doctor
Serial entrepreneur with more than 30 years of clinical and scientific experience
Successful in translating several medical needs into successful therapies (especially for respiratory diseases)
Dr. Gerhard Scheuch
Seed Investor / Founding ShareholderPhysicist / Scientist: Expert in respiratory therapeutics and development of inhaled therapeutics
Advisor to the European Medicines Agency (EMA) and the leading pharmaceutical companies in this field
Serial entrepreneur: Founder of globally successful companies
Business Angel and shareholder of various life science and healthcare start-ups
Erwin J. Schimmer
InvestorDipl. Engineer
Managing Director Vantage Value GmbH
30 years of experience as managing director in building up and managing medium-sized companies
Dr. Dietrich Bruchmann
InvestorCEO of Nuvisan Holding
Excellent track record in progessiv growth strategies, exits and M&A consulting
Expert Advisory Board
From the very start we develop our products with the support of experts: patients and doctors.
Ulrike Nowak
Health ScientistMedical Assistant
Asthmatic patient
Dr. Peter Haidl
Internist pneumologySpecialty hospital Kloster Grafschaft GmbH
Academic Teaching Hospital of the Philipps University of Marburg
Dr. Klaus Klütsch
Internist pneumologyDMP training for asthma and COPD
Supervision of lung sports groups
Frank Hennemann
Patient relations managerPharmaceutical and health advisor
Patient with Alpha1-Antitrypsin Deficiency